ODOMZO (sonidegib) for Locally Advanced Basal Cell Carcinoma - Cancer Therapy Advisor

ODOMZO (sonidegib) for Locally Advanced Basal Cell Carcinoma

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews drug information for ODOMZO (sonidegib), indicated for locally advanced basal cell carcinoma.

Table of Contents

Slide 3: Indication, Dosage, and Administration
Slide 7: Use in Specific Populations
Slide 9: Clinical Pharmacology
Slide 13: Warnings and Precautions
Slide 16: Clinical Safety and Efficacy
Slide 21: Drug Storage and Supply
Slide 23: References

Next hm-slideshow in Slides